Search results
Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy
Yahoo Finance· 23 minutes agoMeanwhile, there are ongoing concerns about the list price of Ozempic. Jørgensen defended the...
CVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 hours agoCVS Health Corporation (NYSE:CVS) Q1 2024 Earnings Call Transcript May 1, 2024 CVS Health...
Drug discount program is exploiting poor patients while corporate giants profit
Minnesota Reformer via Yahoo News· 6 days agoMinnesotans, with their long-valued sense of fairness and decency, would never suggest that Fortune...
What is the Medicare Donut Hole and What Are Your Options?
Penny Hoarder via AOL· 5 days agoMedicare can feel complicated. It’s easy to get overwhelmed when sorting through pages of...
As UnitedHealth grows richer and more powerful, patients get left behind
The Bergen Record via Yahoo Finance· 1 day agoFor instance, it's not uncommon for a PBM like OptumRx to secure enormous discounts from prescription drug companies. Insurers — in this case United Healthcare ...
Novo sees Wegovy sales dip on lower price, tight supply
BioPharma Dive via Yahoo Finance· 5 hours agoThe company is working to gain more favorable insurance coverage and fend off competition from Eli...
CVS posts big earnings miss, cuts profit outlook on higher medical costs
CNBC· 1 day agoCVS Health on Wednesday reported first-quarter revenue and adjusted earnings that missed expectations and slashed its full-year profit outlook, citing higher medical costs that are dogging the ...
Cost and Jaypirca: Financial assistance options, savings, more
Medical News Today· 1 day agoThe cost of the drug can depend on several factors, such as whether Jaypirca has a savings program....
You Can Test Your Blood for 50 Kinds of Cancer
The Atlantic· 3 hours agoIt takes a certain amount of confidence to call your biotech company Grail. According to its website, the Menlo Park–based firm got its name because its “co-founders believed a simple blood ...
Steep Ozempic, Wegovy prices face fresh scrutiny from officials
Axios· 3 days agoWhy it matters: With the drugs now available for heart risks and potentially soon for other...